Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Entero Therapeutics, Inc. | Director | Common Stock | 24.9K | $105K | $4.23 | Jun 11, 2024 | Direct |
Entero Therapeutics, Inc. | Director | Common Stock | 440 | $1.86K | $4.23 | Jun 11, 2024 | Indirect |
First Wave BioPharma, Inc. | Director | Stock Option (right to buy) | 53K | Mar 13, 2024 | Direct | ||
First Wave BioPharma, Inc. | Director | Common Stock, par value $0.0001 per share | 440 | Mar 13, 2024 | Indirect | ||
First Wave BioPharma, Inc. | Director | Series G Non-Voting Convertible Preferred Stock | 141 | Mar 13, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENTO | Entero Therapeutics, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
FWBI | First Wave BioPharma, Inc. | Mar 13, 2024 | 3 | $0 | 4 | Mar 15, 2024 | Director |
FWBI | First Wave BioPharma, Inc. | Mar 13, 2024 | 0 | $0 | 3 | Mar 15, 2024 | Director |